CMS Tests Direct Payment Model for AI Companies in Chronic Care Program as FDA Seeks New Regulatory Framework

CMS Tests Direct Payment Model for AI Companies in Chronic Care Program as FDA Seeks New Regulatory Framework | Health AI Central | Health AI Central